In this study, we examined the effects of WT-GSK-3β and KD-GSK-3β on the sensitivity of MIA-PaCa-2 cells pancreatic cancer cells and MCF-7 breast cancer cells to a panel of chemotherapeutic drugs, signal transduction inhibitors, and nutraceuticals. This evidence concerns the gene GSK3B and familial pancreatic carcinoma.